Wolverine Trading
AVEO

Wolverine Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Wolverine Trading’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,700
Closed -$102K – 6250
2022
Q1 		$102K Buy
+17,700
New +$72.9K ﹤0.01% 4818
2021
Q4 		– Sell
-31,600
Closed -$198K – 7411
2021
Q3 		$198K Buy
+31,600
New +$189K ﹤0.01% 5368
2021
Q2 		– Sell
-37,500
Closed -$260K – 7150
2021
Q1 		$260K Sell
37,500
-15,900
-30% -$137K ﹤0.01% 4661
2020
Q4 		$305K Sell
53,400
-7,900
-13% -$45.2K ﹤0.01% 3730
2020
Q3 		$355K Buy
61,300
+2,300
+4% +$11.4K ﹤0.01% 3183
2020
Q2 		$301K Buy
59,000
+15,600
+36% +$98.5K ﹤0.01% 3347
2020
Q1 		$155K Buy
43,400
+36,390
+519% +$181K ﹤0.01% 3810
2019
Q4 		$44K Sell
7,010
-2,440
-26% -$18K ﹤0.01% 4486
2019
Q3 		$82K Sell
9,450
-1,580
-14% -$11.8K ﹤0.01% 3919
2019
Q2 		$74K Buy
+11,030
New +$94.5K ﹤0.01% 4106
2019
Q1 		– Sell
-18,800
Closed -$306K – 5657
2018
Q4 		$306K Buy
18,800
+9,050
+93% +$199K ﹤0.01% 3164
2018
Q3 		$323K Buy
9,750
+90
+0.9% +$2.31K ﹤0.01% 3658
2018
Q2 		$280K Hold
9,660
– – ﹤0.01% 3894
2018
Q1 		$280K Buy
+9,660
New +$283K ﹤0.01% 3894
2017
Q4 		– Sell
-2,750
Closed -$100K – 5796
2017
Q3 		$100K Sell
2,750
-4,060
-60% -$126K ﹤0.01% 4071
2017
Q2 		$146K Buy
+6,810
New +$53.6K ﹤0.01% 3765
2016
Q4 		– Sell
-4,550
Closed -$40K – 5483
2016
Q3 		$40K Buy
+4,550
New +$42.8K ﹤0.01% 4428

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wolverine Trading's AVEO Position: Q3 2019 in Review

Wolverine Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2019, closing a stake of 1,385 shares — an estimated $10.3K sold.

Wolverine Trading first reported a position in AVEO in Q3 2016 and held it in 8 quarters. The position peaked at $198K in Q3 2017. 59 funds tracked by Wall St. Rank hold AVEO as of Q3 2019.

  • Wolverine Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Wolverine Trading sold 1,385 AVEO Pharmaceuticals, Inc. shares in Q3 2019, an estimated $10.3K.
  • Wolverine Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2016 and held it in 8 quarters.
  • Wolverine Trading's AVEO Pharmaceuticals, Inc. position peaked at $198K in Q3 2017.
  • 59 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2019.

Based on Wolverine Trading's 13F filing for Q3 2019, filed 14 Nov 2019.